BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 17947464)

  • 41. Detection of chromosome 13 deletions by fluorescent in situ hybridization.
    VanWier S; Fonseca R
    Methods Mol Med; 2005; 113():59-69. PubMed ID: 15968095
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of chromosome 12p deletion in plasma cell dyscrasias.
    Jiang N; Qi C; Yu L; Ning Y; An G; Qiu L; Chang H
    Leuk Res; 2012 Jan; 36(1):32-6. PubMed ID: 21982640
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridization.
    Slovak ML; Bedell V; Pagel K; Chang KL; Smith D; Somlo G
    Cancer Genet Cytogenet; 2005 Apr; 158(2):99-109. PubMed ID: 15796956
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes.
    Mohamed AN; Bentley G; Bonnett ML; Zonder J; Al-Katib A
    Am J Hematol; 2007 Dec; 82(12):1080-7. PubMed ID: 17654686
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Cytogenetic characteristics of patients with multiple myeloma in China: analysis of 100 case].
    Deng SH; Xu Y; Wang YF; Mai YJ; Liu XP; Zhao YZ; Zou DH; Wang Y; Qiu LG
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1685-8. PubMed ID: 17825148
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.
    Sezer O; Heider U; Zavrski I; Possinger K
    Haematologica; 2001 Aug; 86(8):837-43. PubMed ID: 11522540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Familial occurrence of multiple myeloma and monoclonal gammopathy of undetermined significance in 5 siblings.
    Bizzaro N; Pasini P
    Haematologica; 1990; 75(1):58-63. PubMed ID: 2110928
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma.
    Wuilleme S; Robillard N; Lodé L; Magrangeas F; Beris H; Harousseau JL; Proffitt J; Minvielle S; Avet-Loiseau H;
    Leukemia; 2005 Feb; 19(2):275-8. PubMed ID: 15538401
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic abnormalities and patterns of antigenic expression in multiple myeloma.
    Mateo G; Castellanos M; Rasillo A; Gutiérrez NC; Montalbán MA; Martín ML; Hernández JM; López-Berges MC; Montejano L; Bladé J; Mateos MV; Sureda A; de la Rubia J; Díaz-Mediavilla J; Pandiella A; Lahuerta JJ; Orfao A; San Miguel JF
    Clin Cancer Res; 2005 May; 11(10):3661-7. PubMed ID: 15897562
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chromosome translocations in multiple myeloma.
    Bergsagel PL; Kuehl WM
    Oncogene; 2001 Sep; 20(40):5611-22. PubMed ID: 11607813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantitative analysis of CKS1B mRNA expression and copy number gain in patients with plasma cell disorders.
    Stella F; Pedrazzini E; Baialardo E; Fantl DB; Schutz N; Slavutsky I
    Blood Cells Mol Dis; 2014 Sep; 53(3):110-7. PubMed ID: 24973170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by multiprobe interphase FISH.
    Cremer FW; Kartal M; Hose D; Bila J; Buck I; Bellos F; Raab MS; Brough M; Moebus A; Hager HD; Goldschmidt H; Moos M; Bartram CR; Jauch A
    Cancer Genet Cytogenet; 2005 Sep; 161(2):116-24. PubMed ID: 16102581
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differences in the distribution of cytogenetic subtypes between multiple myeloma patients with and without a family history of monoclonal gammopathy and multiple myeloma.
    Greenberg AJ; Cousin M; Kumar S; Ketterling RP; Knudson RA; Larson D; Colby C; Scott C; Vachon CM; Vincent Rajkumar S
    Eur J Haematol; 2013 Sep; 91(3):193-195. PubMed ID: 23647020
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular pathogenesis and a consequent classification of multiple myeloma.
    Bergsagel PL; Kuehl WM
    J Clin Oncol; 2005 Sep; 23(26):6333-8. PubMed ID: 16155016
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Multiple myeloma after monoclonal gammopathy of uncertain significance. Study of 10 patients].
    Salgado C; Bladé J; López-Guillermo A; Cervantes F; Montserrat E; Rozman C
    Sangre (Barc); 1993 Oct; 38(5):371-4. PubMed ID: 8140498
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Fluorescence in situ hybridization identifies complex chromosomal aberrations in multiple myeloma].
    Liu SY; Huang JW; Zhang J; Du HP; Jiang H; Li JY; Xue YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):685-8. PubMed ID: 18067084
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance.
    Königsberg R; Ackermann J; Kaufmann H; Zojer N; Urbauer E; Krömer E; Jäger U; Gisslinger H; Schreiber S; Heinz R; Ludwig H; Huber H; Drach J
    Leukemia; 2000 Nov; 14(11):1975-9. PubMed ID: 11069034
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Monoclonal gammopathy of undetermined significance (MGUS) in Mexican mestizos: one institution's experience].
    Ruiz-Delgado GJ; Gómez Rangel JD
    Gac Med Mex; 2004; 140(4):375-9. PubMed ID: 15456147
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy.
    Fonseca R; Oken MM; Harrington D; Bailey RJ; Van Wier SA; Henderson KJ; Kay NE; Van Ness B; Greipp PR; Dewald GW
    Leukemia; 2001 Jun; 15(6):981-6. PubMed ID: 11417487
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Masked hypodiploidy: Hypodiploid acute lymphoblastic leukemia (ALL) mimicking hyperdiploid ALL in children: A report from the Children's Oncology Group.
    Carroll AJ; Shago M; Mikhail FM; Raimondi SC; Hirsch BA; Loh ML; Raetz EA; Borowitz MJ; Wood BL; Maloney KW; Mattano LA; Larsen EC; Gastier-Foster J; Stonerock E; Ell D; Kahwash S; Devidas M; Harvey RC; Chen IL; Willman CL; Hunger SP; Winick NJ; Carroll WL; Rao KW; Heerema NA
    Cancer Genet; 2019 Oct; 238():62-68. PubMed ID: 31425927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.